Beauty Farm Medical and Health Industry Inc. (Beauty Farm) has executed an on-market repurchase of 14,500 ordinary shares on 17 April 2026, paying between HK$20.66 and HK$20.84 per share. The transaction, valued at approximately HK$0.30 million, was carried out under the board-approved mandate dated 27 June 2025.

Following the buyback: • Issued shares (excluding treasury shares) fell to 250.08 million from 250.10 million, a 0.0058% reduction. • Treasury shares increased to 1.51 million, while total issued shares remained unchanged at 251.59 million.

Cumulatively, Beauty Farm has repurchased 1.51 million shares under the current mandate, equal to 0.64% of the 235.80 million shares outstanding when the mandate was granted. The company is restricted from issuing new shares or disposing of treasury shares until 17 May 2026, in line with Hong Kong Stock Exchange regulations.